Improving care delivery for patients with rare cancers: A phase II trial of durvalumab in combination with tremilumimab in subjects with advanced rare tumors in a large community health care system.

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. e18535-e18535
Author(s):  
William Jeffery Edenfield ◽  
Julie C. Martin ◽  
Mark Allen O'Rourke ◽  
Elizabeth H. Cull ◽  
Ki Y. Chung
Sangyo Igaku ◽  
1986 ◽  
Vol 28 (7) ◽  
pp. 530-532
Author(s):  
Tsutomu TAKATA ◽  
B. UKON ◽  
S. TANAKA ◽  
Y. FUKUWATARI ◽  
Y. KAWAGUCHI

2017 ◽  
Vol 152 (5) ◽  
pp. S543
Author(s):  
Kristina M. Seeger ◽  
Walter J. Coyle ◽  
Goetz Laura ◽  
Jason Pan ◽  
Brian Cheng

Sign in / Sign up

Export Citation Format

Share Document